[1]钟仕利 黄晶钟仕利.女性冠脉微血管性心绞痛的诊断及治疗进展[J].心血管病学进展,2019,(7):992.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.007]
　ZHONG shili HUANG jing.Progress in diagnosis and treatment of the microvascular angina in female[J].Advances in Cardiovascular Diseases,2019,(7):992.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.007]
点击复制

女性冠脉微血管性心绞痛的诊断及治疗进展()
分享到：

《心血管病学进展》[ISSN:51-1187/R/CN:1004-3934]

卷:
期数:
2019年7期
页码:
992
栏目:
综述
出版日期:
2019-10-25

文章信息/Info

Title:
Progress in diagnosis and treatment of the microvascular angina in female
作者:
钟仕利1 黄晶1; 2钟仕利
(1. 重庆医科大学研究生院,重庆 400010;2. 重庆医科大学附属第二医院心血管内科,重庆 400010)
Author(s):
ZHONG shili 1HUANG jing 1; 2
(1. Graduate school of chongqing medical universityChongqing 4000102. Department of cardiovascular medicine, the second affiliated hospital of chongqing medical universityChongqing 400010)
关键词:
女性; 微血管性心绞痛; 诊断方法; 治疗方法
Keywords:
The micro-vascular angina; female;  diagnosis;  drug treatment
DOI:
10.16806/j.cnki.issn.1004-3934.2019.07.007
摘要:
微血管性心绞痛的病因目前不完全清楚，目前病因多认为与冠脉内皮功能障碍、冠状动脉微循环功能不全、炎症反应、胰岛素抵抗、雌激素水平不足、冠状动脉痉挛等与微血管性心绞痛的发病密切相关。女性微血管性心绞痛发病率远远高于男性，女性发病多在绝经后，年龄区间多在50-55岁间，故目前女性微血管性心绞痛的诊断及治疗得到了极大的重视，诊断及治疗方案也被单独提出研究，本文对目前女性微血管性心绞痛的诊断方法及药物治疗进展进行阐述。
Abstract:
The etiology of the microvascular angina pectoris is not entirely clear. Previous studes indicatethat the coronary endothelial dysfunction, endothelial activation and inflammation, insulin resistance, estrogen deficiency and coronary artery spasm are closely related to the onset of microvascular angina. However, the incidence of angina in femaleis much higher than in male. The microvascular angina in female mostly happens in menopause. Age range between 50 to 55 years old, so nowadays the diagnosis and treatment of women microvascular angina draw great attention, diagnosis and treatment were also studied separately. This article reviews the current progress of diagnosis and drug treatment of microvascular angina pectoris in female

相似文献/References:

[1]何小刚 袁霄 罗素新.冠状动脉微血管功能障碍诊治的研究进展[J].心血管病学进展,2019,(7):988.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.006]
　HE Xiaogang,YUAN Xiao,LUO Suxin.Diagnosis and Treatment of Coronary Microvascular Dysfunction[J].Advances in Cardiovascular Diseases,2019,(7):988.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.006]
[2]王清腾 金映筑 罗振华 李伟.代谢组学在冠心病中的研究进展[J].心血管病学进展,2021,(9):812.[doi:10.16806/j.cnki.issn.1004-3934.2021.09.000]
　WANG Qingteng JIN Yingzhu LUO Zhenhua LI Wei.Metabolomics in Coronary Heart Disease[J].Advances in Cardiovascular Diseases,2021,(7):812.[doi:10.16806/j.cnki.issn.1004-3934.2021.09.000]
[3]吕华胜 汤宝鹏 芦颜美.心房颤动导管消融后并发症的性别差异研究进展[J].心血管病学进展,2022,(11):961.[doi:10.16806/j.cnki.issn.1004-3934.2022.11.001]
　LV Huasheng,TANG Baopeng,LU Yanmei.Gender Differences in Complications After Catheter Ablation of Atrial Fibrillation[J].Advances in Cardiovascular Diseases,2022,(7):961.[doi:10.16806/j.cnki.issn.1004-3934.2022.11.001]

更新日期/Last Update: 2019-12-16